Merck&Co (NYSE:MRK) reported third quarter earnings that beat analyst's expectations on Thursday and revenue that fell short of forecasts.
The firm reported earnings per share of $1.19 on revenue of $0.73. Analysts polled by forecast EPS of $1.13 on revenue of $10.89B. That compared to EPS of $1.11 on revenue of $10.33B in the same period a year earlier. The company had reported EPS of $1.06 on revenue of $10.47B in the previous quarter.
For the year, Merck&Co shares are up 24.65%, outperforming the S&P 500 which is down 1.03% year to date.
Merck&Co follows other major Healthcare sector earnings this month
On October 16, J&J (NYSE:JNJ) reported third quarter EPS of $2.05 on revenue of $20.35B, compared to forecasts of EPS of $2.03 on revenue of $20.04B.
Novartis ADR earnings beat analyst's expectations on October 18, with third quarter EPS of $1.32 on revenue of $12.78B. analysts expected EPS of $1.31 on revenue of $12.98B
Stay up-to-date on all of the upcoming earnings reports by visiting 's earnings calendar
